Pine Pharmaceuticals, LLC recalls Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceutical
Recalled January 27, 2016 · FDA recall D-0582-2016 · Pine Pharmaceuticals
Hazard
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use. · FDA Class II
Units
N/A
Sold at
Nationwide and Puerto Rico
Description
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Product
Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
Manufacturer(s)
Pine Pharmaceuticals, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →